-
Women may have another choice in emergency contraception (EC) if a current multi-site trial of a potential candidate proves successful. HRA Pharma of Paris, France, has initiated a pivotal multicenter Phase III study to evaluate its proprietary second-generation emergency contraceptive.
-
About one in four U.S. females between the ages of 14 and 59 may have human papillomavirus (HPV), according to results of the first national estimate of the infection.
-
How many men enter the doors of your family planning clinic, and what services can you offer them outside of free condoms? Consider vasectomy: It is simpler, safer, less expensive, and as effective as the currently available methods of female sterilization, according to Contraceptive Technology.
-
Treatment of Periodontitis and Endothelial Function; Does Cost-Conscious Prescribing Hamper Clinical Outcomes?; Induction of Macrolide-Resistant Streptococci; Pulse Pressure and Risk of New-Onset Atrial Fibrillation; Challenges to the Stages of Grief Theory; EKG Abnormalities in Asymptomatic Women: Association with CV Events
-
The clinical presentation of PLS and ALS are similar, and it may be difficult to distinguish them early in the course.
-
Surgery for frontal lobe epilepsy can be very effective in patients with a localized ictal onset zone, focal MRI abnormalities, nocturnal epilepsy and complete resection of the epileptic zone and/or imaging abnormality.
-
Selected patients with anticoagulation-associated intracerebral hemorrhage may benefit from surgical evacuation.
-
Two recent large studies have looked at the effects of various inhaler combinations on outcomes in patients with COPD.
-
New combination chemotherapy protocol for malignant glioma improves 6-month progression-free survival for a dismal disease.
-
The presence of hippocampal sclerosis, by itself, does not predict the clinical course of temporal lobe epilepsy.
